You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
神奇製藥(600613.SH):公司及下屬企業均未獲得熱炎寧合劑生產批准文號
格隆匯 11-14 17:04

格隆匯11月14日丨神奇製藥(600613.SH)發佈股票交易風險提示性公吿,近期,公司關注到熱炎寧合劑相關報道。經核查,公司及下屬企業均未獲得該藥品生產批准文號。“神奇”牌熱炎寧顆粒系神奇製藥下屬孫公司重慶神奇康正醫藥有限公司品牌授權湖南正清製藥集團股份有限公司生產銷售的產品。截止目前,該產品年內銷售收入在100萬元以內,佔公司當期營業收入不超過0.06%;對公司當年毛利貢獻在10萬元以下,佔公司當期淨利潤不超過0.18%。截止目前,該產品的經營銷售不會對公司業績造成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account